Internal Medicine · Dickinson, TX
NPI
1386636025
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
1455 Fm 646 Rd W, Suite # 202
Dickinson, TX, 77539
Phone (832) 738-1710
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
1,885 services
Medicare patients, 2024
597
Average age 77
Drug cost, 2024
$3.7M
42,351 prescriptions
Company payments, 2025
$2,936
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nehme Alkarra was code 99309 (snf e&m), 372 times for 216 patients. In total Nehme Alkarra billed 1,885 services in 42 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 372 | 216 | $83.87 | $31K |
| 99214 Office E&M - Established | Office | 282 | 102 | $78.18 | $22K |
| 99305 SNF E&M | Facility | 165 | 139 | $103.00 | $17K |
| 99349 Home E&M - New and Established | Office | 138 | 45 | $93.27 | $13K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 106 | 106 | $128.51 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 101 | 52 | $62.42 | $6,305 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 98 | 98 | $128.21 | $13K |
| 99213 Office E&M - Established | Office | 89 | 70 | $54.25 | $4,828 |
| 99308 SNF E&M | Facility | 72 | 66 | $58.61 | $4,220 |
| 99304 SNF E&M | Facility | 56 | 53 | $59.46 | $3,330 |
| 99233 Hospital E&M - Subsequent | Facility | 44 | 26 | $92.25 | $4,059 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 43 | 41 | $40.26 | $1,731 |
| 99211 Office E&M - Established | Office | 31 | 11 | $14.83 | $460 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 27 | 19 | $26.98 | $729 |
| 99223 Hospital E&M - Initial | Facility | 25 | 24 | $137.68 | $3,442 |
By year: 2022 $145K for 1,929 services; 2023 $168K for 2,205 services; 2024 $156K for 1,885 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83037 Blood Count | 21 | 19 | $9.52 | $200 |
Medicare prescription drug claims, 2024
In 2024, the drug Nehme Alkarra prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,283 prescriptions and refills. In total Nehme Alkarra wrote 42,351 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,283 | 3,247 | 499 | $34K |
| Amlodipine Besylate Generic | 1,506 | 2,214 | 341 | $15K |
| Furosemide Generic | 1,478 | 1,745 | 264 | $11K |
| Levothyroxine Sodium Generic | 1,409 | 1,774 | 249 | $16K |
| Gabapentin Generic | 1,276 | 1,651 | 278 | $31K |
| Donepezil Hcl Generic | 1,065 | 1,152 | 182 | $29K |
| Eliquis Apixaban | 1,007 | 1,084 | 139 | $383K |
| Memantine Hcl Generic | 892 | 928 | 139 | $41K |
| Lisinopril Generic | 823 | 1,261 | 199 | $9,561 |
| Potassium Chloride Generic | 776 | 875 | 149 | $23K |
| Pantoprazole Sodium Generic | 739 | 1,099 | 186 | $14K |
| Clopidogrel Clopidogrel Bisulfate | 729 | 1,027 | 163 | $12K |
| Metoprolol Tartrate Generic | 723 | 861 | 163 | $7,476 |
| Tamsulosin Hcl Generic | 715 | 937 | 157 | $13K |
| Losartan Potassium Generic | 704 | 950 | 157 | $10K |
Brand drugs: 6,974 claims; generic drugs: 35,259 claims; opioid claims: 424.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nehme Alkarra $2,936 ($2,936 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $708.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 10 | $708 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 12 | $450 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 15 | $413 |
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $362 |
| Abbvie Inc. ABBV | 16 | $221 |
| Corcept Therapeutics CORT | 6 | $140 |
| Aimmune Therapeutics, Inc. | 5 | $101 |
| Amgen Inc. AMGN | 4 | $96.74 |
| Alkermes, Inc. ALKS | 4 | $79.23 |
| GlaxoSmithKline, LLC. GSK | 3 | $61.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.